March 7, 2018 / 9:43 PM / 3 months ago

BRIEF-Evoke Pharma Q4 Loss Per Share $0.02

March 7 (Reuters) - Evoke Pharma Inc:

* EVOKE PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

* Q4 LOSS PER SHARE $0.02

* INCLUDED IN NET LOSS FOR Q4 OF 2017 WAS GAIN OF ABOUT $2.3 MILLION DUE TO CHANGE IN FAIR VALUE OF WARRANT LIABILITY

* AS OF DECEMBER 31, 2017, CO’S CASH AND CASH EQUIVALENTS WERE APPROXIMATELY $7.7 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below